Cargando…

Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resection

BACKGROUND: Hepatitis B surface antigen (HBsAg) is a detectable index after hepatitis B virus (HBV) infection, which is a risk factor of hepatocellular carcinoma (HCC). However, few studies have focused on the expression of HBsAg in HCC patients’ liver tissues. This study aimed to explore the potent...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Ziming, Chen, Jinbin, Wang, Juncheng, Xu, Li, Zhou, Zhongguo, Chen, Minshan, Zhang, Yaojun, Shi, Mude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704243/
https://www.ncbi.nlm.nih.gov/pubmed/32049678
http://dx.doi.org/10.1097/MEG.0000000000001698
_version_ 1783616780267159552
author He, Ziming
Chen, Jinbin
Wang, Juncheng
Xu, Li
Zhou, Zhongguo
Chen, Minshan
Zhang, Yaojun
Shi, Mude
author_facet He, Ziming
Chen, Jinbin
Wang, Juncheng
Xu, Li
Zhou, Zhongguo
Chen, Minshan
Zhang, Yaojun
Shi, Mude
author_sort He, Ziming
collection PubMed
description BACKGROUND: Hepatitis B surface antigen (HBsAg) is a detectable index after hepatitis B virus (HBV) infection, which is a risk factor of hepatocellular carcinoma (HCC). However, few studies have focused on the expression of HBsAg in HCC patients’ liver tissues. This study aimed to explore the potential utility of using HBsAg protein expression in normal liver tissues as a prognostic factor for HCC patients who underwent liver resection. STUDY DESIGN: The study enrolled 100 HCC patients with seropositivity for HBsAg. The liver tissues were collected, and tissue microarrays were constructed. The expression of HBsAg in liver tissues were measured by immunohistochemistry (IHC). Relevant clinical data and follow-up records were collected for analysis. RESULTS: HBsAg expressions was detected in 29 patients (positive group) and was unable to be detected in the remaining 71 patients (negative group). The patients in the positive group had higher HBV DNA levels (P < 0.05) than the patients in the negative group. The overall survival (OS) rate of the positive group was worse than the OS rate of the negative group (P = 0.013). The OS rates after resection at 1 and 2 years in negative group were 90.1% and 85.7%, respectively, while the value in the positive group were 79.3% and 65.5%, respectively. Multivariate analysis showed that HBsAg expression in liver tissues, ascites and alpha-fetoprotein levels were independent factors influencing OS. Similarly, after propensity score matching (PSM), the OS was worse in the positive group than in the negative group, and HBsAg expression could also serve as a predictor for OS (P = 0.039). The OS rates after resection and PSM at 1 and 2 years were 93.2% and 85.9% in the negative group, while the value in the positive group were 79.3% and 65.5%. CONCLUSION: As determined according to grouping based on immunohistochemistry staining results for HBsAg, this study indicated that HBsAg expression in liver tissues could predict the OS of HBV-related HCC patients after liver resection.
format Online
Article
Text
id pubmed-7704243
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams And Wilkins
record_format MEDLINE/PubMed
spelling pubmed-77042432020-12-08 Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resection He, Ziming Chen, Jinbin Wang, Juncheng Xu, Li Zhou, Zhongguo Chen, Minshan Zhang, Yaojun Shi, Mude Eur J Gastroenterol Hepatol Original Articles: Hepatology BACKGROUND: Hepatitis B surface antigen (HBsAg) is a detectable index after hepatitis B virus (HBV) infection, which is a risk factor of hepatocellular carcinoma (HCC). However, few studies have focused on the expression of HBsAg in HCC patients’ liver tissues. This study aimed to explore the potential utility of using HBsAg protein expression in normal liver tissues as a prognostic factor for HCC patients who underwent liver resection. STUDY DESIGN: The study enrolled 100 HCC patients with seropositivity for HBsAg. The liver tissues were collected, and tissue microarrays were constructed. The expression of HBsAg in liver tissues were measured by immunohistochemistry (IHC). Relevant clinical data and follow-up records were collected for analysis. RESULTS: HBsAg expressions was detected in 29 patients (positive group) and was unable to be detected in the remaining 71 patients (negative group). The patients in the positive group had higher HBV DNA levels (P < 0.05) than the patients in the negative group. The overall survival (OS) rate of the positive group was worse than the OS rate of the negative group (P = 0.013). The OS rates after resection at 1 and 2 years in negative group were 90.1% and 85.7%, respectively, while the value in the positive group were 79.3% and 65.5%, respectively. Multivariate analysis showed that HBsAg expression in liver tissues, ascites and alpha-fetoprotein levels were independent factors influencing OS. Similarly, after propensity score matching (PSM), the OS was worse in the positive group than in the negative group, and HBsAg expression could also serve as a predictor for OS (P = 0.039). The OS rates after resection and PSM at 1 and 2 years were 93.2% and 85.9% in the negative group, while the value in the positive group were 79.3% and 65.5%. CONCLUSION: As determined according to grouping based on immunohistochemistry staining results for HBsAg, this study indicated that HBsAg expression in liver tissues could predict the OS of HBV-related HCC patients after liver resection. Lippincott Williams And Wilkins 2020-02-11 2021-01 /pmc/articles/PMC7704243/ /pubmed/32049678 http://dx.doi.org/10.1097/MEG.0000000000001698 Text en Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/) (CC-BY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Articles: Hepatology
He, Ziming
Chen, Jinbin
Wang, Juncheng
Xu, Li
Zhou, Zhongguo
Chen, Minshan
Zhang, Yaojun
Shi, Mude
Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resection
title Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resection
title_full Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resection
title_fullStr Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resection
title_full_unstemmed Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resection
title_short Expression of hepatitis B surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis B virus-related hepatocellular carcinoma patients after liver resection
title_sort expression of hepatitis b surface antigen in liver tissues can serve as a predictor of prognosis for hepatitis b virus-related hepatocellular carcinoma patients after liver resection
topic Original Articles: Hepatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704243/
https://www.ncbi.nlm.nih.gov/pubmed/32049678
http://dx.doi.org/10.1097/MEG.0000000000001698
work_keys_str_mv AT heziming expressionofhepatitisbsurfaceantigeninlivertissuescanserveasapredictorofprognosisforhepatitisbvirusrelatedhepatocellularcarcinomapatientsafterliverresection
AT chenjinbin expressionofhepatitisbsurfaceantigeninlivertissuescanserveasapredictorofprognosisforhepatitisbvirusrelatedhepatocellularcarcinomapatientsafterliverresection
AT wangjuncheng expressionofhepatitisbsurfaceantigeninlivertissuescanserveasapredictorofprognosisforhepatitisbvirusrelatedhepatocellularcarcinomapatientsafterliverresection
AT xuli expressionofhepatitisbsurfaceantigeninlivertissuescanserveasapredictorofprognosisforhepatitisbvirusrelatedhepatocellularcarcinomapatientsafterliverresection
AT zhouzhongguo expressionofhepatitisbsurfaceantigeninlivertissuescanserveasapredictorofprognosisforhepatitisbvirusrelatedhepatocellularcarcinomapatientsafterliverresection
AT chenminshan expressionofhepatitisbsurfaceantigeninlivertissuescanserveasapredictorofprognosisforhepatitisbvirusrelatedhepatocellularcarcinomapatientsafterliverresection
AT zhangyaojun expressionofhepatitisbsurfaceantigeninlivertissuescanserveasapredictorofprognosisforhepatitisbvirusrelatedhepatocellularcarcinomapatientsafterliverresection
AT shimude expressionofhepatitisbsurfaceantigeninlivertissuescanserveasapredictorofprognosisforhepatitisbvirusrelatedhepatocellularcarcinomapatientsafterliverresection